![10yr PP - IPA](https://www.pivotpark.com/wp-content/uploads/2022/10/Wordpress-news.png)
10 years Pivot Park: ImmunoPrecise
ImmunoPrecise’s core strength lies in its ability to quickly and efficiently adapt innovative antibody development technologies into novel therapies,” explains Debby Kruijsen who has been with the Pivot Park located company since 2012, first as a Researcher, now as General Manager.